NRC

Business Context and Reporting Period

Company: National Research Corporation (NRC Health)

Filing Type: Form 10-K (Annual Report)

Reporting Period: Fiscal year ended December 31, 2004

Business Overview: NRC is a leading provider of survey-based performance measurement, analysis, tracking, and improvement services to the healthcare industry in the U.S. and Canada. Its primary offerings include renewable performance tracking services (Qualisys), custom research, educational services, and the syndicated NRC Healthcare Market Guide. The company serves hospitals, health plans, and physicians, helping them measure patient experience and health status to improve quality and profitability.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 10.3% to $29.7 million in 2004, driven by new client acquisitions and expanded scope of work with existing clients.
• Expense Increases: Selling, general, and administrative (SG&A) expenses rose 23.5% to $7.4 million, primarily due to a new sales expansion plan initiated in late 2003, resulting in higher salaries, travel, and recruitment costs. Direct expenses increased 7.0% due to incremental costs of servicing additional clients.
• Margin Compression: Operating margin decreased to 24.9% from 25.9% in 2003, as SG&A expenses grew faster than revenues.
• Cash Flow: Net cash provided by operating activities decreased by approximately $500,000 compared to 2003. This was primarily due to the reversal of $1.6 million in timing items related to government contract billings and payments that occurred in prior years.
• Capital Allocation: The company repurchased 175,300 shares of treasury stock in 2004 for approximately $2.9 million. Additionally, the company announced its first quarterly cash dividend of $0.08 per share in March 2005.

Guidance, Outlook, and Risks

• Outlook: Management expects direct expenses and SG&A as a percentage of total revenues to remain at levels similar to 2004 in 2005. Depreciation and amortization as a percentage of revenue is expected to decrease slightly. The company has budgeted approximately $1.3 million for capital expenditures in 2005.
• Growth Strategy: Future growth is expected to come from expanding the depth of current client programs, cross-selling complementary services, adding new clients, and potential acquisitions.
• Key Risks:
  • Client Concentration: The ten largest clients accounted for 43% of total revenues in 2004. The U.S. Department of Veterans Affairs alone accounted for 12.4% of revenues.
  • Competition: The industry is highly competitive, with larger competitors like Press Ganey possessing greater financial resources. Increased competition could lead to pricing pressure.
  • Contract Renewals: A significant portion of revenue relies on the renewal of annual performance tracking contracts.
  • Accounting Estimates: Revenue recognition relies on percentage-of-completion estimates, which involve significant management judgment regarding project progress and costs.

Investor Verification Checklist

• Verify the renewal rates of the top 10 clients, which represent 43% of revenue, to assess revenue stability.
• Monitor the impact of the new sales expansion plan on future SG&A expense ratios and operating margins.
• Review the timing of government contract billings and payments to understand potential volatility in operating cash flow.
• Assess the competitive landscape, specifically the market share and pricing strategies of larger competitors like Press Ganey.
• Confirm the sustainability of the newly initiated quarterly dividend given the company's historical lack of dividend payments.